Showing results (1871-1880 of 3,162) with videos related to

Sort By:
Pageof 317
Diagnostic Microbiology and Infectious Disease|November 27, 2012
Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010Mariana Castanheira, Lalitagauri M Deshpande, Sarah E Farrell, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2013
Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United StatesRodrigo E Mendes, Robert K Flamm, Patricia A Hogan, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1993
In vitro comparison of E4868, a new trifluoroquinolone, with ciprofloxacin and temafloxacin tested against 5192 recent clinical isolates from five medical centersP R Murray, R N Jones, J A Washington, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 25, 2018
Arteriovenous shunts as venous access in children with haemophiliaK E Thom, T Hölzenbein, N Jones, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephemsR N Jones, M E Erwin, M S Barrett, et al.
Diagnostic Microbiology and Infectious Disease|March 24, 2009
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogensRonald N Jones, Jan M Bell, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1991
In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compoundsR N Jones, M S Barrett, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1991
In vitro activity of RU29246. The metabolite of a new HR916 cephalosporin esterR N Jones, M E Erwin, M S Barrett, et al.
Pageof 317